People · Operator
Named in public records as an officer, director or promoter · active 2010–2024 · Pharmaceuticals, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Aclaris Therapeutics, Inc. | — | Pharmaceuticals | Series C | $192.5M | $611.8M | 2020 |
| Trevena Inc | — | Pharmaceuticals | Series C | $77.5M | $2.1B | 2010 |
| Panorama Medicine, Inc. | — | Biotechnology | Seed | $4.7M | $65.7M | 2021 |
| TamuroBio Inc. | — | Biotechnology | Seed | $4.0M | $177.6M | 2020 |
Maxine Gowen at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Maxine Gowen on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Ketan Patel | 1 | 10 |
| Albert Cha | 1 | 9 |
| David Gordon | 1 | 8 |
| David Solomon | 1 | 8 |
| Stephen Tullman | 1 | 7 |
| Robert Garland | 1 | 7 |
| ANAND MEHRA | 1 | 7 |
| Christopher Mirabelli | 1 | 6 |
| Neal Walker | 1 | 5 |
| Andrew Schiff | 1 | 5 |
| Farah Champsi | 1 | 5 |
| Jimmy Lu | 1 | 4 |
| Ralph Snyderman | 1 | 4 |
| Christopher Powala | 1 | 3 |
| Andrew A. Schiff | 1 | 3 |
| ASHER RUBIN | 1 | 3 |
| Kamil Ali-Jackson | 1 | 3 |
| Leon Moulder, Jr. | 1 | 3 |
| Joseph Monahan | 1 | 3 |
| Andrew Powell | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.